Page last updated: 2024-10-25

ciglitazone and Otitis Media

ciglitazone has been researched along with Otitis Media in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Otitis Media: Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jun, HJ1
Lim, HW1
Choi, J1
Jung, HH1
Chae, SW1

Other Studies

1 other study available for ciglitazone and Otitis Media

ArticleYear
Ciglitazone inhibits cigarette smoke solution-induced inflammatory responses in human middle ear epithelial cells.
    International journal of pediatric otorhinolaryngology, 2012, Volume: 76, Issue:8

    Topics: Blotting, Western; Cells, Cultured; Cytokines; Ear, Middle; Epithelial Cells; Humans; Inflammation;

2012
chemdatabank.com